# ADAM-1: 人工智能与生物信息学在阿尔茨海默病检测及微生物组-临床数据整合中的应用

发布时间：2025年01月14日

`Agent

理由：这篇论文描述了一个多智能体大型语言模型（LLM）框架，即阿尔茨海默病分析模型第一代（ADAM），它通过多智能体架构和检索增强生成（RAG）技术来整合和分析多模态数据。虽然涉及了RAG技术，但核心在于多智能体架构的应用，因此更适合归类为Agent。` `人工智能`

> ADAM-1: AI and Bioinformatics for Alzheimer's Detection and Microbiome-Clinical Data Integrations

# 摘要

> 阿尔茨海默病分析模型第一代（ADAM）是一个多智能体大型语言模型（LLM）框架，旨在整合和分析多模态数据，包括微生物组数据、临床数据集和外部知识库，以提升对阿尔茨海默病（AD）的理解和检测能力。ADAM-1 通过检索增强生成（RAG）技术和多智能体架构，能够从多种数据源中提取见解，并结合文献证据进行情境化分析。与 XGBoost 的对比评估显示，ADAM-1 的平均 F1 分数相近，但方差显著降低，尤其是在小型实验室数据集中表现出更强的鲁棒性和一致性。尽管目前 ADAM-1 专注于二分类任务，但未来版本计划引入更多数据模态，如神经影像和生物标志物，以扩展其在阿尔茨海默病研究和诊断中的应用范围。

> The Alzheimer's Disease Analysis Model Generation 1 (ADAM) is a multi-agent large language model (LLM) framework designed to integrate and analyze multi-modal data, including microbiome profiles, clinical datasets, and external knowledge bases, to enhance the understanding and detection of Alzheimer's disease (AD). By leveraging retrieval-augmented generation (RAG) techniques along with its multi-agent architecture, ADAM-1 synthesizes insights from diverse data sources and contextualizes findings using literature-driven evidence. Comparative evaluation against XGBoost revealed similar mean F1 scores but significantly reduced variance for ADAM-1, highlighting its robustness and consistency, particularly in small laboratory datasets. While currently tailored for binary classification tasks, future iterations aim to incorporate additional data modalities, such as neuroimaging and biomarkers, to broaden the scalability and applicability for Alzheimer's research and diagnostics.

[Arxiv](https://arxiv.org/abs/2501.08324)